寻找基因编辑技术的道德边界

伦理学研究 ›› 2020 (6): 117-124.

寻找基因编辑技术的道德边界

陈化, 马永慧

出版日期:2020-11-10 发布日期:2021-12-09
作者简介:陈化,南方医科大学马克思主义学院教授,法学博士;马永慧,厦门大学医学院生命伦理学研究中心副教授,哲学博士。
基金资助:
国家社会科学基金重大项目“大数据时代生物样本库的哲学研究”（19ZDA039）; 国家社会科学基金青年项目“人体微生态研究的伦理挑战及对策研究”(16CZX064); 2019年度厦门大学校长基金年度项目“人类基因编辑的伦理考量与规制研究”（20720191024）

Online:2020-11-10 Published:2021-12-09

摘要/Abstract

摘要： 理性评价基因编辑技术应用及其治理,需要依托于不偏不倚的观察者角色与“应当”的伦理学话语。从规范伦理学进路看,生殖系基因编辑技术因违反契约主义而不能得到伦理辩护,但契约主义对于基因编辑技术的阐释力较为有限。技术与伦理之间的动态视野要求我们,以发展的价值观审视生殖系基因编辑的伦理问题,而公共福祉是其应用的道德边界。公共福祉是人类实践自由的内在理由,它要求以保持“人的存在”为前提,禁止应用于基因增强。为此,需要建构基于权利为基础的全球治理框架,依托表达公共理性的公众参与,以及获得基因编辑治疗的正当性。

关键词: 基因编辑技术, 道德边界, 公共福祉, 全球治理框架

陈化, 马永慧. 寻找基因编辑技术的道德边界[J]. 伦理学研究, 2020(6): 117-124.

参考文献

[1] 汉斯·约纳斯.技术、医学与伦理学:责任原理的实践[M].张荣,译.上海:上海译文出版社,2008.
[2] Friedmann T,Roblin R. Gene therapy for human genetic disease?[J].Science.1972(Mar).
[3] German Ethics Council.Intervening in the human germline Opinion-executive summary and recommendations[R]. Berlin:German ethics Council,2019.
[4] H. Gene Blocker.Ethics An Introduction[M].Haven Publications,1988.
[5] Nietzsche,Friedrich.On the Genealogy of Morals[M].Oxford Paperbacks; 2008.
[6] 托马斯.威廉斯. 伦理学与哲学的限度[M].陈嘉映,译.北京:商务印书馆,2018.
[7] Brandt R.The definition of an ‘Ideal Observer’ in Ethics[A].In:Darwal S,ed. Philosophy and Phenomenological Research[C].Boulder:Westview Press,1998.
[8] Gert B. Moral Impartiality[J].Midwest Studies in Philosophy1995(20).
[9] M.Scanlon T.Contractualism and Utilitarianism[A].Amatia Sen & Bernard Williams,Utilitaianism and Beyond[C].New York:Cambridge University press; 1982.
[11] Nie JB aAC.He Jiankui’s Genetic Misadventure,Part 3:What Are Major Ethical Issues?[EB/OL]. The Hastings Center Report:Hastings Bioethics Forum; 2019(Jan).
[10] 陈晓平.试论人类基因编辑的伦理界限——从道德、哲学和宗教的角度看“贺建奎事件”[J].自然辩证法通讯,2019(7).
[12] 易显飞.人类生殖细胞基因编辑的伦理问题及其消解[J].武汉大学学报(哲学社会科学版),2019(4).
[13] 库尔特.拜尔茨. 基因伦理学[M].马怀琪,译.北京:华夏出版社,2001.
[14] Engelhardt THJ.Human nature genetically re‐engineered:Moral responsibilities to future generations[A]. E. Agius & S. Busuttil. Germ‐line intervention and our responsibilities to future generations[C].Dordrecht Boston, London:Kluwer Academic Publisher,1998.
[15] Nadia Primc. Do we have a right to an unmanipulated genome?The human genome as the common heritage of mankind[J].Bioethics2020(1).
[16] Seppe S,Heidi M. Does human genome editing reinforce or violate human dignity?[J].Bioethics,2020(1).DOI:10.1111/bioe.12607
[17] 樊浩.基因技术的道德哲学革命[J].中国社会科学,2006(1).
[18] Cohen J. I feel an obligation to be balanced,Noted biologist comes to defense of gene editing babies[J].Science,2018(Nov.).
[19] Court of Justice of the European Union,C-528/16,EU:C:2018:583. in its judgment on mutagenesis through genome editing,the Court did not adhere to its own standards when itself-reliantly considered,without referring to any scientific source,that the precautionary principle was applicable due to “risks for the environment or human health linked to the use of new techniques/methods of mutagenesis[such as CRISPR-Cas][…that]might be similar to those which result from the production and release of a[genetically modified organism]through transgenesis”.
[20] 托马斯.斯坎伦. 我们彼此负有什么义务[M].陈代东等,译.北京:人民出版社,2008.
[21] 李石.论“基因编辑”技术的伦理界限[J].伦理学研究,2019(2).
[22] 伯纳德.威廉斯. 道德运气[M].徐向东, 译.上海:上海译文出版社,2007.
[23] Bioethic NCo.Genome editing and human reproduction:Social and ethical issues[R]. Nuffield Council on Bioethics,2018.
[24] 安东尼.吉登斯. 现代性的后果[M].赵旭东等,译.南京:译林出版社,2000.
[25] Hayden. EC. Should you edit your children’s genes[J].Nature2016(Mar).
[26] 吕克.费希. 超人类革命:生物技术如何改变我们的未来[M].周行,译.长沙:湖南科技出版社,2017.
[27] 甘绍平.对人类增强的伦理反思[J].哲学研究,2018(1).
[28] Beverley A. Townsend. Human genome editing:how to prevent rogue actors[J].BMC Medical Ethics,2020(9).
[29] Jasanoff S,Hurlbut JB. Saha K. CRISPR democracy:gene editing and the need for inclusive deliberation[J].Issues Sci Technol.2015(1).
[30] Ruipeng Lei RQ. Reboot ethics governance in China[J].Nature,2019(May).
[31] Schleidgen Sebastian,Dederer HansGeorg,Sgodda Susan,et al. Human germline editing in the era of CRISPR-Cas:risk and uncertainty,inter-generational responsibility,therapeutic legitimacy[J].BMC Medical Ethics,2020(09).
[32] Schleidgen Sebastian, Dederer HansGeorg, Sgodda Susan, et al. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy[J].BMC Medical Ethics,2020(9).